Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Associated Press - Tuesday September 11, 2001
Paul Elias, AP Biotechnology Writer
Immune Response Corp. funded the school's research on the drug and then tried to block publication of a study questioning its effectiveness.
The report, published in the Journal of the American Medical Association in November, claimed the vaccine Remmune failed to reduce the amount of HIV in the bloodstream or slow the progression of the disease. Remmune is made from a disabled form of HIV, the virus that causes AIDS.
Immune Response agreed to drop its demands that UCSF pay the company at least $7 million it alleged it lost because of the damaging report. The Carlsbad-based company also agreed to turn over data it originally withheld from the UCSF research team.
"We are happy to see the resolution of this dispute on terms that do not compromise the rights of university researchers to publish sponsored research findings," said Zach Hall, UCSF executive vice chancellor.
There was no comment from the company on the reason for its decision.
The feud highlighted the increasing influence companies wield over research they help fund. On Sunday, the editors of the world's most prestigious medical journals unveiled a new policy aimed at limiting that influence.
010911
AP010915
Copyright © 2001 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. ÆGIS. All materials appearing on ÆGIS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS, or the party credited as the provider of the content. Feedback/Contact Us.